These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification]. Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577 [TBL] [Abstract][Full Text] [Related]
5. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956 [TBL] [Abstract][Full Text] [Related]
6. [Is pathogenetically-founded therapy of chronic inflammatory bowel disease in sight?]. Miller B Z Gastroenterol; 1993 Nov; 31 Suppl 5():30-4. PubMed ID: 8197797 [No Abstract] [Full Text] [Related]
7. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4. Lobos EA; Sharon P; Stenson WF Dig Dis Sci; 1987 Dec; 32(12):1380-8. PubMed ID: 2826090 [TBL] [Abstract][Full Text] [Related]
8. [Detection of increased permeability of the intestinal mucosa in chronic inflammatory bowel diseases]. Karbach U Z Gastroenterol Verh; 1989 Jul; 24():40-4. PubMed ID: 2474980 [No Abstract] [Full Text] [Related]
9. Determination of 15-keto-13,14-dihydro-prostaglandin E2 and prostaglandin D2 in human colonic tissue using a chemiluminescence enzyme immunoassay with catalase as labeling enzyme. Lange K; Simmet T; Peskar BM; Peskar BA Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():35-8. PubMed ID: 2936119 [No Abstract] [Full Text] [Related]
10. [Significance of prostaglandins and leukotrienes in gastroenterology]. Peskar BM Internist (Berl); 1986 Oct; 27(10):637-42. PubMed ID: 3025128 [No Abstract] [Full Text] [Related]
11. [Pathogenesis of chronic inflammatory bowel diseases]. Ewe K Z Gastroenterol Verh; 1983 Apr; 18():8-20. PubMed ID: 6192613 [No Abstract] [Full Text] [Related]
14. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease. Olbe L Scand J Gastroenterol; 2008; 43(2):234-41. PubMed ID: 17918000 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of inflammatory bowel disease. Stenson WF Year Immunol; 1985; ():214-8. PubMed ID: 3033942 [No Abstract] [Full Text] [Related]
16. Cadherins: an integral role in inflammatory bowel disease and mucosal restitution. Zbar AP; Simopoulos C; Karayiannakis AJ J Gastroenterol; 2004; 39(5):413-21. PubMed ID: 15175938 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431 [TBL] [Abstract][Full Text] [Related]
18. Proceedings: Bidirectional sodium flux across the intestinal mucosa in Crohn's disease. Allan RN; Steinberg DM; Dixon K; Cooke WT Gut; 1974 Oct; 15(10):839-40. PubMed ID: 4434971 [No Abstract] [Full Text] [Related]
19. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. Agius LM J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386 [TBL] [Abstract][Full Text] [Related]
20. Etiology and pathogenesis of inflammatory bowel disease. Schmidt C; Stallmach A Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]